Diabetic Foot Ulcers Treatment Market Explore Growth and Analysis Top Players 3M Healthcare, Coloplast A/S, B.Braun Melsungen AG, Acelity L.P. Inc., Smith & Nephew Plc., Medtronic Plc, ConvaTec Inc, and Mölnlycke Health Care.

Diabetic Foot Ulcers Treatment Market is expected to have a highly positive outlook for the next five years 2018–2026 according to a recently released Diabetic Foot Ulcers Treatment Market research report. The report has been added in his large database by Coherent Market Insights.”

The major takeaways in the report are product segment analysis, application segment analysis, regional segment analysis and data of the major Diabetic Foot Ulcers Treatment Market players from around the world. The report presents an introductory as well as detailed information about the Diabetic Foot Ulcers Treatment Market through a well-organized layout divided into easy to understand chapters.

Download PDF Brochure@ https://www.coherentmarketinsights.com/insight/request-pdf/1357

Diabetic foot ulcers is a common disease observed in diabetic patients. According to facts presented in fact sheet 2017, Center for Disease and Prevention, among the total diabetic population, 60%–80% suffers from foot ulcers. New and innovative treatments in wound dressings and therapy devices is expected to augment the diabetic foot ulcers treatment market growth. Since there are less availability of products to treat diabetic foot ulcers by device, provides a great opportunity for key players as well as new entrants to enter the diabetic foot ulcers treatment market. Furthermore, Negative pressure wound therapy devices essential for the management of diabetic foot ulcers, as also expected to favor the growth of diabetic foot ulcers treatment market.

Market Dynamics

Diabetic foot ulcers treatment market is mainly driven by increasing prevalence of diabetes. According to World Health Organization, it was estimated that 422 million adults were suffering from diabetes, in 2014 globally. Furthermore, according to National Diabetes Statistics Report 2017, 30.3 million people in the U.S. have been estimated to have diabetes. This is expected to favor growth of the diabetic foot ulcers treatment market.

Furthermore, according to the data published by Agency for Healthcare Research & Quality (AHRQ) in October 2014, over 2.5 million individuals in the U.S. develop pressure ulcers annually, which costs the U.S. health care system around US$ 9.1 billion to US$ 11.6 billion per year

Increasing number of product launches and innovative therapies are also expected to drive the diabetic foot ulcers treatment market growth. For instance, in December 2017, FDA approved shockwave therapy by Dermapace for diabetic foot ulcers treatment. The FDA also approved a spray, Granulox by infirst Healthcare Ltd, in November 2017, for the treatment of diabetic foot ulcers.

Request for Customization@ https://www.coherentmarketinsights.com/insight/request-customization/1357

Diabetic Foot Ulcers Treatment Market Taxonomy:

Global Diabetic Foot Ulcers Treatment Market, By Ulcers:
Neuropathic Ulcers
Neuro-Ischemic Ulcers
Global Diabetic Foot Ulcers Treatment Market, By Product Type:
Wound Care Dressings
Foam Dressing
Hydrocolloid Dressing
Hydrogel Dressing
Alginate Dressing
Other Dressing
Biologics
Growth factors
Skin Graft and Skin Substitutes
Wound Care Therapy Devices
Negative Pressure Wound Devices
Hyperbaric Oxygen Therapy
Other Wound Care Therapy Devices
Others
Global Diabetic Foot Ulcers Treatment Market, By End User:
Hospital
Clinics
Ambulatory Surgical Center
Homecare Setting

Request a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/1357

Technological advancement in treatment of diabetic foot ulcers is expected to drive growth of the diabetic foot ulcers treatment market.

Introduction of several novel wound healing agents, which are administrated as a topical ointment or spray or injected directly into the wound is expected to favor growth of the diabetic foot ulcers treatment market. For instance, in August 2017, ViroMed started phase III trial of its VM202 gene therapy for non-healing diabetic foot ulcers and concomitant peripheral artery disease (PAD).

Furthermore, development of various device such as shock wave, for the treatment of diabetic foot ulcers is also expected to favor growth of the diabetic foot ulcers treatment market in the near future. For instance, in December 2017, the U.S. Food and Drug Administration gave approval for marketing of SANUWAVE Health, Inc., Dermapace System, which is a first shock wave device intended to treat diabetic foot ulcers.

Some major players operating in the global diabetic foot ulcers treatment market include 3M Healthcare, Coloplast A/S, B.Braun Melsungen AG, Acelity L.P. Inc., Smith & Nephew Plc., Medtronic Plc, ConvaTec Inc, and Mölnlycke Health Care.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.